Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
|
| In millions, except per share items | Sep-30-16 | Sep-30-15 | Sep-30-14 | Sep-30-13 | Sep-30-12 | Sep-30-11 | Sep-30-10 | Sep-30-09 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K/A | 10-K | 10-K |
| Revenues: |
| Radiation Measurement | 104.2 | 106.0 | 113.6 | 109.3 | 107.6 | 99.9 | 100.3 | |
| Medical Physics | 39.2 | 35.4 | 32.2 | 30.9 | 30.9 | 20.6 | 14.0 | |
| Medical Products | 5.8 | 9.9 | 9.3 | 9.5 | 13.5 | | | |
| Total revenues [+] | 149.2 | 151.3 | 155.1 | 149.7 | 152.1 | 120.5 | 114.4 | 93.8 |
| Products | 18.6 | 22.5 | 27.4 | 23.2 | 27.3 | 6.1 | | |
| Services | 130.6 | 128.8 | 127.7 | 126.5 | 124.8 | 114.4 | | |
| Revenue growth [+] | -1.4% | -2.4% | 3.6% | -1.6% | 26.3% | 5.3% | 21.9% | |
| Radiation Measurement | -1.7% | -6.7% | 3.9% | 1.6% | 7.8% | -0.5% | | |
| Medical Physics | 10.7% | 10.0% | 4.4% | -0.3% | 50.3% | 46.7% | | |
| Medical Products | -41.3% | 6.4% | -2.2% | -29.8% | | | | |
| Cost of goods sold [+] | 73.8 | 72.6 | 74.2 | 71.1 | 65.4 | 47.5 | 44.5 | 30.8 |
| Cost of product sales | 7.0 | 8.7 | 12.5 | 11.2 | 11.8 | 4.3 | | |
| Cost of services | 66.8 | 63.9 | 61.6 | 59.9 | 53.6 | 43.2 | | |
| Gross profit | 75.5 | 78.7 | 80.9 | 78.6 | 86.7 | 72.9 | 69.9 | 63.1 |
| Gross margin | 50.6% | 52.0% | 52.2% | 52.5% | 57.0% | 60.6% | 61.1% | 67.2% |
| Selling, general and administrative | 48.8 | 54.0 | 54.9 | 51.1 | 59.0 | 38.1 | 35.3 | 30.5 |
| Equity in earnings | 1.5 | 2.3 | 2.9 | 3.3 | 3.1 | 2.2 | 1.5 | 1.6 |
| Other operating expenses | | | | | -7.7 | -1.5 | | |
| EBITDA [+] | 39.2 | 39.4 | 42.9 | 45.8 | 50.5 | 46.6 | 42.8 | 39.9 |
| EBITDA growth | -0.4% | -8.2% | -6.4% | -9.4% | 8.5% | 8.7% | 7.2% | |
| EBITDA margin | 26.3% | 26.0% | 27.6% | 30.6% | 33.2% | 38.6% | 37.4% | 42.6% |
| Depreciation | 9.1 | 10.1 | 9.9 | 11.0 | 8.7 | 7.0 | 5.8 | 5.8 |
| EBITA | 30.1 | 29.3 | 32.9 | 34.8 | 41.8 | 39.6 | 37.1 | 34.1 |
| EBITA margin | 20.2% | 19.4% | 21.2% | 23.3% | 27.5% | 32.9% | 32.4% | 36.3% |
| Amortization of intangibles | 2.0 | 2.2 | 4.0 | 4.1 | 3.3 | 1.0 | 0.9 | |
| EBIT [+] | 28.1 | 27.0 | 28.9 | 30.7 | 38.6 | 38.6 | 36.1 | 34.1 |
| EBIT growth | 4.0% | -6.5% | -5.8% | -20.3% | 0.0% | 6.7% | 6.0% | |
| EBIT margin | 18.8% | 17.9% | 18.7% | 20.5% | 25.3% | 32.0% | 31.6% | 36.3% |
| Non-recurring items [+] | | 1.0 | 66.0 | 24.1 | 7.7 | 1.5 | | |
| Asset impairment | | 20.8 | 62.2 | 22.7 | 3.4 | | | |
| Restructuring charges | | 1.0 | 3.8 | 1.4 | 4.3 | 1.5 | 2.0 | 0.4 |
| Interest expense | 3.4 | 4.4 | 3.4 | 4.3 | 3.4 | 0.3 | 0.1 | |
| Interest expense | 3.4 | 4.4 | 3.4 | 4.3 | 3.4 | 0.3 | 0.1 | |
| Other income (expense), net [+] | 3.6 | -0.3 | 0.0 | 0.7 | 0.2 | -0.1 | 0.0 | 0.6 |
| Acquisition-related costs | | | | | | | 2.0 | 0.4 |
| Other | 3.6 | -0.3 | 0.0 | 0.7 | 0.2 | -0.1 | 0.0 | 0.6 |
| Pre-tax income | 28.4 | 21.3 | -40.5 | 3.1 | 27.6 | 36.7 | 36.0 | 34.7 |
| Income taxes | 9.9 | 6.3 | -15.8 | -0.6 | 8.2 | 11.5 | 11.9 | 11.1 |
| Tax rate | 34.9% | 29.4% | 39.0% | | 29.8% | 31.4% | 33.0% | 31.9% |
| Minority interest | 0.7 | 0.5 | 0.5 | 0.9 | 0.8 | 0.7 | 0.5 | 0.3 |
| Net income | 17.8 | 14.5 | -25.2 | 2.8 | 18.5 | 24.5 | 23.7 | 23.4 |
| Net margin | 11.9% | 9.6% | -16.3% | 1.9% | 12.2% | 20.4% | 20.7% | 24.9% |
| |
| Basic EPS [+] | $1.86 | $1.53 | ($2.65) | $0.29 | $1.98 | $2.61 | $2.54 | $2.51 |
| Growth | 21.9% | -157.8% | -997.4% | -85.1% | -24.4% | 2.7% | 1.1% | |
| Diluted EPS [+] | $1.86 | $1.52 | ($2.65) | $0.29 | $1.97 | $2.59 | $2.53 | $2.49 |
| Growth | 21.7% | -157.6% | -1001.9% | -85.1% | -24.1% | 2.2% | 1.5% | |
| |
| Dividends per share [+] | $1.10 | $1.67 | $2.21 | $2.22 | $2.22 | $2.19 | $2.16 | $2.08 |
| Growth | -34.1% | -24.5% | -0.2% | -0.1% | 1.1% | 1.6% | 3.6% | |
| |
| Shares outstanding (basic) [+] | 9.5 | 9.5 | 9.5 | 9.4 | 9.4 | 9.4 | 9.3 | 9.3 |
| Growth | 0.2% | -0.1% | 1.0% | 0.5% | -0.1% | 0.9% | 0.2% | |
| Shares outstanding (diluted) [+] | 9.6 | 9.5 | 9.5 | 9.5 | 9.4 | 9.5 | 9.3 | 9.4 |
| Growth | 0.3% | 0.2% | 0.4% | 0.5% | -0.4% | 1.4% | -0.2% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|